159 related articles for article (PubMed ID: 31311583)
1. miR-34a as hub of T cell regulation networks.
Hart M; Walch-Rückheim B; Krammes L; Kehl T; Rheinheimer S; Tänzer T; Glombitza B; Sester M; Lenhof HP; Keller A; Meese E
J Immunother Cancer; 2019 Jul; 7(1):187. PubMed ID: 31311583
[TBL] [Abstract][Full Text] [Related]
2. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4
Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509
[TBL] [Abstract][Full Text] [Related]
3. Regulatory and immunomodulatory role of miR-34a in T cell immunity.
Taheri F; Ebrahimi SO; Shareef S; Reiisi S
Life Sci; 2020 Dec; 262():118209. PubMed ID: 32763292
[TBL] [Abstract][Full Text] [Related]
4. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.
Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ
BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665
[TBL] [Abstract][Full Text] [Related]
5. miR-34a: a new player in the regulation of T cell function by modulation of NF-κB signaling.
Hart M; Walch-Rückheim B; Friedmann KS; Rheinheimer S; Tänzer T; Glombitza B; Sester M; Lenhof HP; Hoth M; Schwarz EC; Keller A; Meese E
Cell Death Dis; 2019 Jan; 10(2):46. PubMed ID: 30718475
[TBL] [Abstract][Full Text] [Related]
6. Identification of miR-34a-target interactions by a combined network based and experimental approach.
Hart M; Rheinheimer S; Leidinger P; Backes C; Menegatti J; Fehlmann T; Grässer F; Keller A; Meese E
Oncotarget; 2016 Jun; 7(23):34288-99. PubMed ID: 27144431
[TBL] [Abstract][Full Text] [Related]
7. The down-regulation of hsa_circ_0012919, the sponge for
Zhang C; Wang X; Chen Y; Wu Z; Zhang C; Shi W
Clin Sci (Lond); 2018 Nov; 132(21):2285-2298. PubMed ID: 30237316
[TBL] [Abstract][Full Text] [Related]
8. Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling.
Lal A; Thomas MP; Altschuler G; Navarro F; O'Day E; Li XL; Concepcion C; Han YC; Thiery J; Rajani DK; Deutsch A; Hofmann O; Ventura A; Hide W; Lieberman J
PLoS Genet; 2011 Nov; 7(11):e1002363. PubMed ID: 22102825
[TBL] [Abstract][Full Text] [Related]
9. MiR-34a-3p alters proliferation and apoptosis of meningioma cells
Werner TV; Hart M; Nickels R; Kim YJ; Menger MD; Bohle RM; Keller A; Ludwig N; Meese E
Aging (Albany NY); 2017 Mar; 9(3):932-954. PubMed ID: 28340489
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics functional analysis of let-7a, miR-34a, and miR-199a/b reveals novel insights into immune system pathways and cancer hallmarks for hepatocellular carcinoma.
Soliman B; Salem A; Ghazy M; Abu-Shahba N; El Hefnawi M
Tumour Biol; 2018 May; 40(5):1010428318773675. PubMed ID: 29775159
[TBL] [Abstract][Full Text] [Related]
11. Verification of microRNA expression in human endometrial adenocarcinoma.
Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K
BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+T lymphocytes of relapsing-remitting multiple sclerosis patients.
Ghadiri N; Emamnia N; Ganjalikhani-Hakemi M; Ghaedi K; Etemadifar M; Salehi M; Shirzad H; Nasr-Esfahani MH
Gene; 2018 Jun; 659():109-117. PubMed ID: 29551498
[TBL] [Abstract][Full Text] [Related]
13. MiR-568 inhibits the activation and function of CD4⁺ T cells and Treg cells by targeting NFAT5.
Li W; Kong LB; Li JT; Guo ZY; Xue Q; Yang T; Meng YL; Jin BQ; Wen WH; Yang AG
Int Immunol; 2014 May; 26(5):269-81. PubMed ID: 24355664
[TBL] [Abstract][Full Text] [Related]
14. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.
Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X
Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
Ye J; Li L; Feng P; Wan J; Li J
Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.
Pang RT; Leung CO; Ye TM; Liu W; Chiu PC; Lam KK; Lee KF; Yeung WS
Carcinogenesis; 2010 Jun; 31(6):1037-44. PubMed ID: 20351093
[TBL] [Abstract][Full Text] [Related]
18. MiR-34a is differentially expressed in dorsal root ganglia in a rat model of chronic neuropathic pain.
Brandenburger T; Johannsen L; Prassek V; Kuebart A; Raile J; Wohlfromm S; Köhrer K; Huhn R; Hollmann MW; Hermanns H
Neurosci Lett; 2019 Aug; 708():134365. PubMed ID: 31278961
[TBL] [Abstract][Full Text] [Related]
19. An integrated approach of predicted miR-34a targets identifies a signature for gastric cancer.
Tang T; Su R; Wang B; Zhang Y
Oncol Lett; 2015 Aug; 10(2):653-660. PubMed ID: 26622549
[TBL] [Abstract][Full Text] [Related]
20. Modulation of intracellular calcium signaling by microRNA-34a-5p.
Diener C; Hart M; Alansary D; Poth V; Walch-Rückheim B; Menegatti J; Grässer F; Fehlmann T; Rheinheimer S; Niemeyer BA; Lenhof HP; Keller A; Meese E
Cell Death Dis; 2018 Sep; 9(10):1008. PubMed ID: 30262862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
